Trulieve CEO Kim Rivers Contributes to President Trump's Marijuana Rescheduling Order

S. Attorney General Pam Bondi to reschedule marijuana from Schedule I to Schedule III. Kim Rivers, CEO of Trulieve, attended the signing at the White House and received a marker from the president. Rivers described the event as significant after years of advocacy.

For two years, Rivers, along with Howard Kessler and other business leaders, lobbied for the reclassification. Marijuana has been classified as Schedule I since 1970 under federal law. The rescheduling, if completed, would represent a major federal drug policy change.

stated that President Trump made the decision independently, believing it benefits Americans. She keeps the signed marker and a hat from the president in her office. 2 billion in 2025 sales and 239 stores across eight states, Rivers has become a key figure in the $30 billion cannabis industry.

Trulieve holds a 35% market share in Florida's $2 billion medical cannabis market. The company donated to Trump-related political groups and his inaugural committee, according to Federal Elections Commission data. Rivers attended fundraising events and meetings in the Oval Office.

early December 2025, Rivers met with President Trump, joined by Secretary of Health and Human Services Robert F. , Centers for Medicare & Medicaid Services administrator Mehmet Oz, Kessler, Scotts Miracle-Gro CEO Jim Hagedorn, and others. They discussed reclassifying marijuana.

President Trump referenced input from individuals including Mike Tyson during the meeting. Speaker of the House Mike Johnson advised against the order during a phone call, citing moral concerns. Bradford County Sheriff Gordon Smith, also present, supported regulation.

President Trump decided to proceed and directed staff to draft the order.

cofounded Trulieve in 2016, starting with one dispensary in Tallahassee. In 2024, Trulieve contributed $150 million to a campaign for Florida's Amendment 3 to legalize recreational marijuana, which failed. President Trump publicly supported the amendment in September 2024.

Rivers met Trump in August 2024 in Bedminster, New Jersey. She continues to advocate for industry regulation and medical research.